Can-Fite BioPharma Company Profile (NASDAQ:CANF)

Analyst Ratings

Consensus Ratings for Can-Fite BioPharma (NASDAQ:CANF) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Can-Fite BioPharma (NASDAQ:CANF)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Can-Fite BioPharma (NASDAQ:CANF)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
5/31/2016Q116($0.09)($0.12)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Can-Fite BioPharma (NASDAQ:CANF)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Can-Fite BioPharma (NASDAQ:CANF)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Can-Fite BioPharma (NASDAQ:CANF)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Can-Fite BioPharma (NASDAQ:CANF)
DateHeadline
07/05/16 03:01 PMMid-Morning Market Update: Markets Open Lower; Tesla's Deliveries Hit Near 2-Year Low
07/05/16 03:01 PMCan-Fite Bio's lead product candidate flunks mid-stage glaucoma study; shares down 23% premarket
06/15/16 03:08 PMCan-Fite Reports New Data Showing its Psoriasis Drug May Offer Efficacy Similar to Industry Leading Biologics Without Harmful Side Effects
06/15/16 03:08 PMCan-Fite BioPharma (CANF) Announces New Data Showing CF101 May Offer Efficacy Similar to Leading Biologics Without Harmful Side Effects
06/03/16 07:20 AMCan-Fite finalizes design of late-stage study of CF101 in rheumatoid arthritis, enrollment to start no later than Q3 - Can-Fite BioPharma (CANF-0.3%) reaches agreement with the European Medicines Agency (EMA) on the final design of a global Phase 3 clinical trial assessing lead product candidate Piclidenoson (CF101) for the treatment of rheumatoid arthritis (RA).
05/25/16 01:50 PMNew migraine drugs promise relief — but at a steep price - The Verge - The VergeNew migraine drugs promise relief — but at a steep priceThe VergeI couldn't do anything but swallow an Advil and lie down in my room in the dark. I missed a lot of childhood dance ... The new migraine-specific drug is being developed by four pharmaceutical companies in the US and they may receive regulatory approval ...and more »
05/19/16 01:36 PMBroker Roundup For Can-Fite Biopharma Ltd (CANF) - Share Trading News - Broker Roundup For Can-Fite Biopharma Ltd (CANF)Share Trading News03/30/2015 – Can-Fite Biopharma Ltd was downgraded to “neutral” by analysts at Roth Capital. They now have a USD 2.4 price target on the stock. The share price of Can-Fite Biopharma Ltd (CANF) was up +0.00% during the last trading session, with a day ...
05/12/16 08:34 AMAnalysts Expect Can Fite Biopharma Ltd (NASDAQ:CANF) to Post ($0.09) EPS - Washington News Wire - Washington News WireAnalysts Expect Can Fite Biopharma Ltd (NASDAQ:CANF) to Post ($0.09) EPSWashington News WireShares of Can Fite Biopharma Ltd (NASDAQ:CANF) have received an average broker rating score of 0.00 () from the zero analysts that cover the stock, Zacks Investment Research reports. Shares of Can Fite Biopharma (NASDAQ:CANF) traded down ...and more »
05/07/16 07:36 AMBroker Outlook For Can-Fite Biopharma Ltd (CANF) - Share Trading News - Broker Outlook For Can-Fite Biopharma Ltd (CANF)Share Trading NewsCan Fite Biofarma Ltd signed distribution contracts with a Kwang Dong Pharmaceutical Co. allowing distribution of CF101 for arthritis in Korea and Seikagaku Corp. for distribution in Japan. The Company operates three subsidiaries, Ultratrend Ltd ...and more »
05/02/16 08:17 AMCan-Fite BioPharma (CANF) Will Present CF602 Data at AUA 2016 - StreetInsider.com - Can-Fite BioPharma (CANF) Will Present CF602 Data at AUA 2016StreetInsider.comCan-Fite BioPharma Ltd. (NYSE: CANF) announced the Company's Director of Molecular Biology, Shira Cohen will present data at the American Urology Association's Annual Meeting (AUA 2016), which will take place in San Diego, California on May 6-10, ...Can-Fite to Present Data on CF602 in the Treatment of Erectile Dysfunction at American Urology Association's Annual ...PR Newswire (press release)all 2 news articles »
05/02/16 06:00 AMCan-Fite to Present Data on CF602 in the Treatment of Erectile Dysfunction at American Urology Association's Annual Meeting - [PR Newswire] - PETACH TIKVA, Israel, May 2, 2016 /PRNewswire/ -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory diseases, cancer, and sexual dysfunction, today announced the Company's Director of Molecular Biology, Shira Cohen will present data at the American Urology Association's Annual Meeting (AUA 2016), which will take place in San Diego, California on May 6-10, 2016. The presentation titled, "CF602 Improves Erectile Dysfunction in Diabetic Rats" will be part of the session titled, "Sexual Function/Dysfunction: Basic Research & Pathophysiology II" on Tuesday, May 10 from 10:30am – 12:30pm PT. Single Dose Efficacy: CF602 demonstrated statistically significant full recovery from erectile dysfunction after a single dose treatment in a diabetic rat model.
04/29/16 06:00 AMCan-Fite to Present at Joseph Gunnar & Co.'s Pioneers 2016 Conference in New York City on May 5, 2016 - [PR Newswire] - PETACH TIKVA, Israel, April 29, 2016 /PRNewswire/ -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory diseases, cancer, and sexual dysfunction, today announced the Company's Chief Financial Officer, Motti Farbstein, will present at Joseph Gunnar & Co.'s Pioneers 2016 Conference in New York City. Mr. Farbstein will present at 4:30 pm ET on Thursday, May 5, 2016 at the New York Palace Hotel. Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI) is an advanced clinical stage drug development Company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, inflammatory disease and sexual dysfunction.
04/14/16 01:28 PMCan-Fite Biopharma Ltd (CANF) Latest Broker Coverage - Risers & Fallers - Can-Fite Biopharma Ltd (CANF) Latest Broker CoverageRisers & FallersA number of investment brokers have recently updated their price targets on shares of Can-Fite Biopharma Ltd (CANF). According to the latest broker reports outstanding on Thursday 14th of April, 0 analysts have a rating of “strong buy”, 1 analysts “buy ...
04/13/16 02:09 PMRecently Changed Price Targets On Can-Fite Biopharma Ltd (CANF) - Risers & Fallers - Recently Changed Price Targets On Can-Fite Biopharma Ltd (CANF)Risers & FallersA number of investment brokers have recently updated their price targets on shares of Can-Fite Biopharma Ltd (CANF). According to the latest broker reports 0 analysts have a rating of “buy”, 1 analysts “outperform”, 0 analysts “hold”, 0 analysts ...
04/13/16 02:09 PMCan-Fite Biopharma Ltd (CANF) Analyst Review - Risers & Fallers - Can-Fite Biopharma Ltd (CANF) Analyst ReviewRisers & FallersA number of investment brokers have recently updated their price targets on shares of Can-Fite Biopharma Ltd (CANF). According to the latest broker reports outstanding on Tuesday 12th of April, 0 analysts have a rating of “strong buy”, 1 analysts “buy ...UnitedHealth Group (NYSE:UNH) & Can Fite Biopharma (NYSEMKT:CANF) Investor's Watch ListWall Street 24What Analyst Recommends Average EPS? Boston Scientific Corporation (NYSE:BSX), Can-Fite Biopharma Ltd ...WsNews 4investorsBiotechnology Gainers: MannKind Corp. (NASDAQ:MNKD), Viking Therapeutics, Inc. (NASDAQ:VKTX), Can-Fite ...Benchmark Monitorall 5 news articles »
04/13/16 02:09 PMLatest Analyst Ratings For Can-Fite Biopharma Ltd (CANF) - Share Trading News - Latest Analyst Ratings For Can-Fite Biopharma Ltd (CANF)Share Trading NewsRecently analysts working for a variety of stock market brokerages have changed their consensus ratings and price targets on shares of Can-Fite Biopharma Ltd (CANF). The most recent broker reports which have been released note that 0 analysts have a ...and more »
04/12/16 12:03 PMCan-Fite Biopharma Ltd (CANF) Broker Price Targets For The Coming Week - Share Trading News - Can-Fite Biopharma Ltd (CANF) Broker Price Targets For The Coming WeekShare Trading NewsRecently some investment brokers have made changes to their outstanding price targets on shares of Can-Fite Biopharma Ltd (CANF). According to data from Reuters, 0 analysts have a rating of “buy”, 1 analysts “outperform”, 0 analysts “hold”, 0 analysts ...and more »
04/12/16 12:03 PMUnitedHealth Group (NYSE:UNH) & Can Fite Biopharma (NYSEMKT:CANF) Investor's Watch List - Wall Street 24 - UnitedHealth Group (NYSE:UNH) & Can Fite Biopharma (NYSEMKT:CANF) Investor's Watch ListWall Street 24Can-Fite BioPharma Ltd. a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory diseases, cancer, and sexual dysfunction, stated new findings for its drug candidate, CF602, showing statistically noteworthy ...What Analyst Recommends Average EPS? Boston Scientific Corporation (NYSE:BSX), Can-Fite Biopharma Ltd ...WsNews 4investorsall 3 news articles »
04/12/16 12:03 PMCan-Fite BioPharma (CANF) Announces Positive New Pre-Clinical Data for CF602 - StreetInsider.com - Can-Fite BioPharma (CANF) Announces Positive New Pre-Clinical Data for CF602StreetInsider.comCan-Fite BioPharma Ltd. (NYSE: CANF) today reported new findings for its drug candidate, CF602, showing statistically significant full recovery from erectile dysfunction after one single dose treatment in a pre-clinical diabetic model. Can-Fite plans ...and more »
04/09/16 11:30 AMAnalyst Review: Can-Fite Biopharma Ltd (CANF) - Risers & Fallers - Analyst Review: Can-Fite Biopharma Ltd (CANF)Risers & FallersA number of investment brokers have recently updated their price targets on shares of Can-Fite Biopharma Ltd (CANF). According to the latest broker reports outstanding on Friday 8th of April, 0 analysts have a rating of “strong buy”, 1 analysts “buy ...
04/05/16 01:38 PMVersartis (NASDAQ:VSAR) & Can Fite Biopharma (NYSEMKT:CANF) Notable Runners - Wall Street 24 - Versartis (NASDAQ:VSAR) & Can Fite Biopharma (NYSEMKT:CANF) Notable RunnersWall Street 24Can-Fite BioPharma Ltd. a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, recently declared it has filed its 2015 Annual Report on Form 20-F with ...and more »
04/01/16 02:00 PMCan-Fite Biopharma Ltd (CANF) Latest Broker Views - Risers & Fallers - Can-Fite Biopharma Ltd (CANF) Latest Broker ViewsRisers & FallersA number of investment brokers have recently updated their price targets on shares of Can-Fite Biopharma Ltd (CANF). According to the latest broker reports outstanding on Thursday 31st of March, 0 analysts have a rating of “strong buy”, 1 analysts “buy ...
04/01/16 02:00 PMForm 6-K Can-Fite BioPharma Ltd. For: Apr 01 - StreetInsider.com - Form 6-K Can-Fite BioPharma Ltd. For: Apr 01StreetInsider.comPETACH TIKVA, Israel, April 1, 2016 -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, ...and more »
03/30/16 01:27 PMAfter Last Week What Do Analysts Think Of Can-Fite Biopharma Ltd (CANF) - Share Trading News - After Last Week What Do Analysts Think Of Can-Fite Biopharma Ltd (CANF)Share Trading NewsRecently some investment brokers have made changes to their outstanding price targets on shares of Can-Fite Biopharma Ltd (CANF). According to data from Reuters, 0 analysts have a rating of “buy”, 1 analysts “outperform”, 0 analysts “hold”, 0 analysts ...
03/25/16 02:01 PMUpdated Price Targets On Can-Fite Biopharma Ltd (CANF) - Risers & Fallers - Updated Price Targets On Can-Fite Biopharma Ltd (CANF)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Can-Fite Biopharma Ltd (CANF). The latest broker reports which are currently outstanding on Thursday 24th of March state 0 analysts have a rating of “strong buy”, 1 ...Stocks to Watch: Can-Fite BioPharma Ltd. (NYSEMKT:CANF), Turquoise Hill Resources (NYSE:TRQ), The Western ...KC Registerall 4 news articles »
03/25/16 02:01 PMPrice Target Update: Can-Fite Biopharma Ltd (CANF) - SCSUCollegian - Price Target Update: Can-Fite Biopharma Ltd (CANF)SCSUCollegianCan-Fite Biopharma Ltd (NYSEMKT:CANF) shares are expected to touch $6.75 in the short term. This short term price target has been shared by 2 analysts. However, the standard deviation of short term price estimate has been valued at 1.06. The target ...Can-Fite Biopharma Ltd (CANF) Updated Price TargetsFTSE Newsall 2 news articles »
03/20/16 01:41 PMCan-Fite Biopharma Ltd (CANF): What Do Brokers Think For The Coming Week? - Share Trading News - Can-Fite Biopharma Ltd (CANF): What Do Brokers Think For The Coming Week?Share Trading NewsRecently analysts working for a variety of stock market brokerages have changed their consensus ratings and price targets on shares of Can-Fite Biopharma Ltd (CANF). The most recent broker reports which have been released note that 0 analysts have a ...
03/20/16 01:41 PMAfter Last Week What Do Analysts Think Of Can-Fite Biopharma Ltd (CANF)? - Risers & Fallers - After Last Week What Do Analysts Think Of Can-Fite Biopharma Ltd (CANF)?Risers & FallersA number of investment brokers have recently updated their price targets on shares of Can-Fite Biopharma Ltd (CANF). According to the latest broker reports 0 analysts have a rating of “buy”, 1 analysts “outperform”, 0 analysts “hold”, 0 analysts ...
03/19/16 11:44 AMPotter and Penniman: “The System Is Rigged Against Regular People” - BillMoyers.com - BillMoyers.comPotter and Penniman: “The System Is Rigged Against Regular People”BillMoyers.comBig money has created its own system and we note that Eve can't escape the system, her parents can't, you can't, we can't collectively escape the system that has been created and that so many people see as being rigged against them. When you talk about ...and more »
03/18/16 01:19 PMCan-Fite BioPharma (CANF) Submits EMA Protocol Design for Phase III Trial of Lead Compound CF101 - StreetInsider.com - Can-Fite BioPharma (CANF) Submits EMA Protocol Design for Phase III Trial of Lead Compound CF101StreetInsider.comCan-Fite BioPharma Ltd. (NYSE: CANF) today announced it has submitted to the European Medicines Agency (EMA) a protocol design for its Phase III trial and Registration Plan for the Company's lead compound CF101 in the treatment of rheumatoid arthritis ...Can-Fite Biopharma Ltd (CANF) Broker UpdatesRisers & FallersCan-Fite Submits Phase III Protocol Design and Registration Plan to European Medicines Agency (EMA) for CF101 in ...PR Newswire (press release)all 4 news articles »
03/17/16 01:03 PMMaking Impressive Motion: Can-Fite BioPharma (NYSEMKT:CANF), Dynatronics Corp. (NASDAQ:DYNT), Whiting ... - Property Mentor - Making Impressive Motion: Can-Fite BioPharma (NYSEMKT:CANF), Dynatronics Corp. (NASDAQ:DYNT), Whiting ...Property MentorCan-Fite BioPharma Ltd. (NYSE MKT: CANF) announced that Shira Cohen, the Company's Director of Molecular Biology Labs, presented at the American Academy of Dermatology's 74th Annual Meeting which took place in Washington D.C. on March 4 – 8, ...and more »
03/17/16 01:03 PMCan-Fite Biopharma Ltd (CANF) New Analyst Ratings - Share Trading News - Can-Fite Biopharma Ltd (CANF) New Analyst RatingsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Can-Fite Biopharma Ltd (CANF). The latest reports which are currently in issue on Tuesday 15th of March state 0 analysts have a rating of “strong buy”, 1 analysts “buy”, ...
03/14/16 07:13 AMThe Latest: Clinton says foreign leaders wary of Trump - WKOW - The Latest: Clinton says foreign leaders wary of TrumpWKOWBut Clinton added that she thinks the death penalty should still be kept "in reserve" for limited cases in the federal judicial system, citing the Oklahoma City bombing and the 9/11 attacks as examples. "But what happened to ... The candidate will be ...and more »
03/12/16 12:41 PMThe CNN Miami Republican debate transcript, annotated - Washington Post - Washington PostThe CNN Miami Republican debate transcript, annotatedWashington PostWhy should these voters who don't like these trade deals trust that you will fight for them all the time and not just in election years? CRUZ: Actually that's incorrect. There are two different agreements. There's TPA and TPP .... When my parents came ...
03/12/16 12:41 PMTranscript of the Republican Presidential Debate in Florida - New York Times - New York TimesTranscript of the Republican Presidential Debate in FloridaNew York TimesTiming lights will be visible. Those lights will warn you when time is up. And as you requested, a bell will also sound, like this. (BELL SOUND) We know that each of you wants to debate these important issues, but please wait until you are called upon ...and more »
03/12/16 12:41 PMTranscript of Republican debate in Miami, full text - CNN International - CNN InternationalTranscript of Republican debate in Miami, full textCNN InternationalJoining me in the questioning this evening will be Washington Times reporter Stephen Dinan, CNN Chief Political Correspondent Dana Bash, and Salem Radio's Hugh Hewitt. ..... When my parents came, they had a very limited education. ...... We can't fight ...Final RUSH Transcript//CNN Republican Presidential Primary Debate- University of MiamiCNN (blog)all 233 news articles »
03/12/16 12:41 PMCan-Fite Biopharma Ltd (CANF) Price Target Changes - Risers & Fallers - Can-Fite Biopharma Ltd (CANF) Price Target ChangesRisers & FallersA number of investment brokers have recently updated their price targets on shares of Can-Fite Biopharma Ltd (CANF). According to the latest broker reports outstanding on Friday 11th of March, 0 analysts have a rating of “strong buy”, 1 analysts “buy”, ...
03/09/16 01:56 PMThere Is No FDA For Education. Maybe There Should Be - NPR - WFDDThere Is No FDA For Education. Maybe There Should BeNPRAnd after a half-century, Kane writes in a new article, we should have made much more progress toward closing the achievement gap: the educational equivalent of the fight against cancer. Failure to do more, ... The tools he had were limited; his ...Civil Rights Act of 1964 - Wikipedia, the free encyclopediaWikipediaConnecting to Practice: How we can put education research to work : Education NextEducation NextEquality of educational opportunity - U.S. Department of EducationU.S. Department of EducationWikipediaall 26 news articles »
03/04/16 01:57 PMActive Stocks Need to Consider: Can-Fite BioPharma Ltd. (NYSEMKT:CANF), Micsurgedmi Corporation (NASDAQ ... - Seneca Globe - Active Stocks Need to Consider: Can-Fite BioPharma Ltd. (NYSEMKT:CANF), Micsurgedmi Corporation (NASDAQ ...Seneca GlobeShares of Can-Fite BioPharma Ltd. (NYSEMKT:CANF) has price volatility of 6.69% in last 5 days trading session, while shares of firm closed at $2.39 knocking up 3.91% in last session. Can-Fite BioPharma (CANF) will deliver a poster presentation titled, ...and more »
03/04/16 01:57 PMStocks Preparing To Gain Concentrations: Can-Fite BioPharma (CANF), Micsurgedmi (MSCC), Sotheby's (OFFER) - Seneca Globe - Stocks Preparing To Gain Concentrations: Can-Fite BioPharma (CANF), Micsurgedmi (MSCC), Sotheby's (OFFER)Seneca GlobeCan-Fite BioPharma Ltd. (NYSEMKT:CANF) closed at $2.39 with jumps up of 3.91% in last trading session. Can-Fite BioPharma Ltd. (CANF) reported that Shira Cohen, firm's Director of Molecular Biology Labs, would present at the American Academy of ...
03/03/16 01:53 PMTaylor Sheridan On The Drug War And His Evolution From 'Sons Of Anarchy' Actor To 'Sicario' Screenwriter - UPROXX - UPROXXTaylor Sheridan On The Drug War And His Evolution From 'Sons Of Anarchy' Actor To 'Sicario' ScreenwriterUPROXXI was doing what I did. Now, I'm a good-looking guy, but I'm not real good-looking, and there's a whole lot of people that are. I was fine with what I was doing, but creatively I was feeling very limited. Also, I'd became fascinated with the notion of ...
03/03/16 01:53 PMHottest Manufacturing Stocks Now - CRMD TUMI JOY TSE - Investorplace.com - Hottest Manufacturing Stocks Now - CRMD TUMI JOY TSEInvestorplace.comSupernus Pharmaceuticals Inc (SUPN): SUPN stock is up 8.83% today. Can-Fite Biopharma Ltd Sponsore (CANF): CANF stock is up 6.52% today. Aeterna Zentaris (AEZS): AEZS stock is up 8.03% today. Stratasys Ltd (SSYS): SSYS stock is up 5.65% today.
03/03/16 01:53 PMCan-Fite to Present Psoriasis Data at American Academy of Dermatology's 74th Annual Meeting in Washington D.C. on ... - PR Newswire (press release) - Can-Fite to Present Psoriasis Data at American Academy of Dermatology's 74th Annual Meeting in Washington D.C. on ...PR Newswire (press release)PETACH TIKVA, Israel, March 3, 2016 /PRNewswire/ -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and ...and more »
03/02/16 01:47 PMVodafone Unit Scraps Neotel Deal After Two-Year Regulatory Fight - Bloomberg - BloombergVodafone Unit Scraps Neotel Deal After Two-Year Regulatory FightBloombergVodacom has the most customers in South Africa with 34.1 million at the end of 2015, and crosstown rivals including MTN Group Ltd., Cell C Pty Ltd. and Telkom SA SOC Ltd. argued the tie-up would give the company a dominant position in the market.and more »
03/02/16 01:47 PMOpinion: Republicans slide towards existential crisis - Deutsche Welle - Deutsche WelleOpinion: Republicans slide towards existential crisisDeutsche WelleThe fight seems over for Florida Senator Marco Rubio - he was unable to fulfill the hopes young moderate Republicans had put on him after his recent attacks on Trump. So now the ... Not even by a party for which he entered the election campaign and ...and more »
02/29/16 01:30 PMStocks on the Move: Alphabet Inc (NASDAQ:GOOG), American Airlines Group Inc. (NASDAQ:AAL), Can-Fite ... - Property Mentor - Stocks on the Move: Alphabet Inc (NASDAQ:GOOG), American Airlines Group Inc. (NASDAQ:AAL), Can-Fite ...Property MentorCan-Fite BioPharma Ltd. (NYSEMKT:CANF) provides an detailed overview of Can-Fite BioPharma Ltd. scenario. Report includes top line data relating on Can-Fite BioPharma Ltd. Global clinical trials scenario. This report on Can-Fite BioPharma Ltd. also ...
02/27/16 01:14 PMCritics' Picks: Feb 26 - March 3, 2016 - Los Angeles Times - Los Angeles TimesCritics' Picks: Feb 26 - March 3, 2016Los Angeles TimesSteven Spielberg's superior directing skills and fine acting from Tom Hanks and Mark Rylance do the trick in this espionage thriller about a successful insurance lawyer who has to defend a Soviet spy and then attempt to trade him to the Russians for ...
02/27/16 01:14 PMAsk Sam | Sam Smith opens his mailbag | 2.26.2016 - Bulls.com - Bulls.comAsk Sam | Sam Smith opens his mailbag | 2.26.2016Bulls.comBut Curry; yeah, I can do that. I've occasionally heard discussion over the years about how to make the game more accessible to more. Like why can't someone like Jeremy Lin play a bigger role? The emphasis on three-point shooting is one way that aids ...and more »
02/27/16 01:14 PMRevaluing Darling Ingredients Demonstrates Opportunity - Seeking Alpha - Seeking AlphaRevaluing Darling Ingredients Demonstrates OpportunitySeeking AlphaDarling Ingredients is primarily a spread-based business, driven by how much it has to pay for raw collection, how much it costs to transport and render raw materials, and how much it can receive for rendered materials and products. Over the last 20 ...and more »
02/27/16 01:14 PMLatest Analysts Reports On Can-Fite Biopharma Ltd (CANF) - Risers & Fallers - Latest Analysts Reports On Can-Fite Biopharma Ltd (CANF)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Can-Fite Biopharma Ltd (CANF). The latest broker reports which have been released state 0 analysts have a rating of “buy”, 1 analysts “outperform”, 0 analysts “hold”, ...

Social

About Can-Fite BioPharma

Can Fite Biofarma Ltd is an Israel-based biopharmaceutical company. The Company develops new treatments for autoimmune diseases and cancer. The Company's drugs are CF101 for Psoriasis treatment, RA treatment, for the treatment of Keratoconjunctictivitis Sicca, for the treatment of Glaucoma, among others; and CF102 for the treatment of liver diseases. The Company has a research infrastructure including research laboratories and animal house facilities run by the development team. Can Fite Biofarma Ltd signed distribution contracts with a Kwang Dong Pharmaceutical Co. allowing distribution of CF101 for arthritis in Korea and Seikagaku Corp. for distribution in Japan. The Company operates three subsidiaries, Ultratrend Ltd, EyeFite Ltd and OphathaliX Inc.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CANF
  • CUSIP:
Key Metrics:
  • Previous Close: $2.13
  • 50 Day Moving Average: $2.48
  • 200 Day Moving Average: $2.52
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $29.54M
  • Current Year EPS Consensus Estimate: $-0.370 EPS
  • Next Year EPS Consensus Estimate: $-0.360 EPS
Additional Links:
Can-Fite BioPharma (NASDAQ:CANF) Chart for Wednesday, July, 27, 2016